{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:58:53Z","timestamp":1772143133296,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.annpat.2026.02.006","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:01:37Z","timestamp":1772139697000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quoi de neuf dans les lymphomes B primitifs du m\u00e9diastin et les lymphomes fronti\u00e8res du m\u00e9diastin\u00a0?"],"prefix":"10.1016","author":[{"given":"Marie","family":"Donzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Traverse-Glehen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2026.02.006_bib0175","doi-asserted-by":"crossref","first-page":"115369","DOI":"10.1016\/j.ejca.2025.115369","article-title":"Primary mediastinal B-cell lymphoma (PMBCL): the LYSA pragmatic guidelines","volume":"220","author":"Renaud","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annpat.2026.02.006_bib0180","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.3390\/cancers15194866","article-title":"Molecular characterization of primary mediastinal large B-cell lymphomas","volume":"15","author":"Donzel","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.annpat.2026.02.006_bib0185","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1182\/bloodadvances.2023011169","article-title":"High PDL1\/PDL2\u00a0gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma","volume":"7","author":"Camus","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.annpat.2026.02.006_bib0190","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":"MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.02.006_bib0195","doi-asserted-by":"crossref","DOI":"10.21037\/aol-22-13","article-title":"State of the art in the diagnosis, biology and treatment of primary mediastinal B-cell lymphoma: a review","volume":"6","author":"Camus","year":"2022","journal-title":"Ann Lymphoma"},{"key":"10.1016\/j.annpat.2026.02.006_bib0200","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/bloodadvances.2020001923","article-title":"Gene expression profiling of gray zone lymphoma","volume":"4","author":"Sarkozy","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.annpat.2026.02.006_bib0205","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jmoldx.2017.07.007","article-title":"Determination of molecular subtypes of diffuse large B-cell lymphoma using a reverse transcriptase multiplex ligation-dependent probe amplification classifier: a CALYM study","volume":"19","author":"Bob\u00e9e","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.annpat.2026.02.006_bib0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41408-020-0322-5","article-title":"Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma","volume":"10","author":"Bob\u00e9e","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.annpat.2026.02.006_bib0215","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue","volume":"123","author":"Scott","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.02.006_bib0220","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/10428194.2021.2010060","article-title":"Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study","volume":"63","author":"Camus","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.annpat.2026.02.006_bib0225","first-page":"1575","article-title":"Cell-Free DNA for genomic analysis in primary mediastinal large B-cell lymphoma","volume":"12","author":"Rivas-Delgado","year":"2022","journal-title":"Diagn Basel Switz"},{"key":"10.1016\/j.annpat.2026.02.006_bib0230","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/s41587-021-00981-w","article-title":"Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA","volume":"39","author":"Kurtz","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.annpat.2026.02.006_bib0235","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2024-202508","article-title":"Circulating tumor DNA for primary mediastinal B-cell lymphoma genotyping: a prospective multicenter study","volume":"144","author":"Camus","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.02.006_bib0240","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41375-023-01995-w","article-title":"Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms","volume":"37","author":"Kalmbach","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.annpat.2026.02.006_bib0245","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/hon.3132","article-title":"Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors","volume":"41","author":"Mozas","year":"2023","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.annpat.2026.02.006_bib0250","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23\u00a0expression, 1p36\/TNFRSF14\u00a0abnormalities, and STAT6\u00a0mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.02.006_bib0255","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41408-021-00491-7","article-title":"Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study","volume":"11","author":"W\u00e4sterlid","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.annpat.2026.02.006_bib0260","doi-asserted-by":"crossref","first-page":"v91","DOI":"10.1093\/annonc\/mdw175","article-title":"Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Vitolo","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annpat.2026.02.006_bib0265","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3324\/haematol.2023.283446","article-title":"Improved survival for dose-intensive chemotherapy in primary mediastinal B-cell lymphoma: a systematic review and meta-analysis of 4,068\u00a0patients","volume":"109","author":"Cook","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.annpat.2026.02.006_bib0270","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022019340","article-title":"Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170","author":"Zinzani","year":"2023","journal-title":"Blood J"},{"key":"10.1016\/j.annpat.2026.02.006_bib0275","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1200\/JCO.19.01492","article-title":"Nivolumab combined with brentuximab vedotin for relapsed\/refractory primary mediastinal large B-cell lymphoma: efficacy and safety from the phase II CheckMate 436\u00a0study","volume":"37","author":"Zinzani","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2026.02.006_bib0280","doi-asserted-by":"crossref","first-page":"e70091","DOI":"10.1002\/hem3.70091","article-title":"Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19\u00a0CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry","volume":"9","author":"Galtier","year":"2025","journal-title":"HemaSphere"},{"key":"10.1016\/j.annpat.2026.02.006_bib0285","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.02.006_bib0290","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.annpat.2026.02.006_bib0295","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/PAS.0000000000001198","article-title":"Gray-zone lymphoma between cHL and large B-cell lymphoma: a histopathologic series from the LYSA","volume":"43","author":"Sarkozy","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2026.02.006_bib0300","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3324\/haematol.2016.152256","article-title":"Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99\u00a0patients from the Lymphoma Study Association","volume":"102","author":"Sarkozy","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.annpat.2026.02.006_bib0305","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2026.02.006_bib0310","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bjh.16331","article-title":"Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma\/diffuse large B-cell lymphoma, a clinico-pathological series of 25\u00a0cases","volume":"189","author":"Aussedat","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annpat.2026.02.006_bib0315","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.2020007507","article-title":"Mutational landscape of gray zone lymphoma","volume":"137","author":"Sarkozy","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.02.006_bib0320","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","article-title":"Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations","volume":"24","author":"Eberle","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.02.006_bib0325","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2024.285266","article-title":"A targeted gene signature stratifying mediastinal gray zone lymphoma into classical HL-like or PMBL-like subtypes","author":"Gargano","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.annpat.2026.02.006_bib0330","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1182\/blood-2014-03-564906","article-title":"A prospective study of mediastinal gray-zone lymphoma","volume":"124","author":"Wilson","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.annpat.2026.02.006_bib0335","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.annpat.2026.02.006_bib0170","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ijrobp.2025.08.012","article-title":"The role of radiation therapy in the management of gray zone lymphoma","volume":"123","author":"Saifi","year":"2025","journal-title":"Int J Radiat Oncol"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649826000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649826000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:01:42Z","timestamp":1772139702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649826000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"alternative-id":["S0242649826000271"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2026.02.006","relation":{},"ISSN":["0242-6498"],"issn-type":[{"value":"0242-6498","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quoi de neuf dans les lymphomes B primitifs du m\u00e9diastin et les lymphomes fronti\u00e8res du m\u00e9diastin\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2026.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}